


Healthcare Industry News: HIV/AIDS
News Release - October 26, 2006
Human Genome Sciences Announces Positive Special Protocol Assessment From FDA for Phase 3 Clinical Trials of LymphoStat-B(TM) In Systemic Lupus Erythematosus
Source: Human Genome Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
